The diabetes drug, rosiglitazone (Avandia) may increase risk for bone thinning or osteoporosis, which could help explain why diabetics may have an increased risk of fractures. The study found that the drug increased the activity of the cells that degrade bones in mice; according to results published online in Nature Medicine. GlaxoSmithKline, the company that markets the drug, has already acknowledged that a study has found that there is a higher risk of fractures among women who take Avandia. » Continue Reading

The United States Food and Drug Administration (FDA) and drug company GIaxoSmithKline (GSK) are alerting doctors about rare reports of worsening eye complications in diabetic patients who are taking the drugs Avandia or Avandamet. » Continue Reading

Related terms:

• diabetes drug for eye problem